Developmentally Restricted Differentiation Antigens Are Targets for Immunotherapy in Epithelial Ovarian Carcinoma

International Journal of Gynecological Pathology- United States

doi 10.1097/pgp.0b013e318275a550

Full Text

Abstract

Available in

Date

Authors

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Autoantibodies to Tumor-Associated Antigens in Epithelial Ovarian Carcinoma

Journal of Oncology
Oncology
2009English

Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy

Cancer Research
Cancer ResearchOncology
2012English

MHC Class I-Presented Tumor Antigens Identified in Ovarian Cancer by Immunoproteomic Analysis Are Targets for T-Cell Responses Against Breast and Ovarian Cancer

Clinical Cancer Research
Cancer ResearchOncology
2011English

Recent Perspectives of Epithelial Ovarian Carcinoma (Review)

Oncology Letters
Cancer ResearchOncology
2016English

Preclinical Immunotherapy With Cytokine-Induced Killer Lymphocytes Against Epithelial Ovarian Cancer

Scientific Reports
Multidisciplinary
2020English

Epithelial-Type Systemic Breast Carcinoma Cells With a Restricted Mesenchymal Transition Are a Major Source of Metastasis

Science advances
Multidisciplinary
2019English

Basal Epithelial Stem Cells Are Efficient Targets for Prostate Cancer Initiation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

Expression of HPIP in Epithelial Ovarian Carcinoma: A Clinicopathological Study

OncoTargets and Therapy
OncologyPharmacology
2016English

Secondary Cytoreductive Surgery for Recurrent Epithelial Ovarian Carcinoma: Proposal for Patients Selection

British Journal of Cancer
Cancer ResearchOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy